Luis Cano
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
- Surgery 11
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
- Organ Transplantation Techniques and Outcomes 4
- Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Liver Disease and Transplantation 4
- Co-authors
- Miluska Castillo (2 shared papers)Sandro Casavilca‐Zambrano (7 shared papers)Pascal Pineau (6 shared papers)Stéphane Bertani (6 shared papers)César Beltrán (1 shared paper)Eloy Ruíz (5 shared papers)Agnès Marchio (3 shared papers)Eric Deharo (3 shared papers)
- Journals
- Scientific Reports (4 papers)Surgery (3 papers)Clinical & Translational Oncology (1 paper)British Journal of Cancer (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- FrancePeruUnited States
In The Last Decade
Luis Cano
32 papers receiving 328 citations
Peers
Comparison fields: 5 of 72
- Hepatology 93
- Oncology 101
- Cancer Research 47
- Epidemiology 77
- Biophysics 12
Countries citing papers authored by Luis Cano
This map shows the geographic impact of Luis Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Cano more than expected).
Fields of papers citing papers by Luis Cano
This network shows the impact of papers produced by Luis Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Cano. The network helps show where Luis Cano may publish in the future.
Co-authors
The 25 scholars most cited alongside Luis Cano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 47 | |
| 2 | 2017 | 41 | |
| 3 | 2023 | 25 | |
| 4 | 2020 | 24 | |
| 5 | 2018 | 23 | |
| 6 | 2016 | 21 | |
| 7 | 2021 | 19 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 12 | |
| 10 | 2020 | 10 | |
| 11 | 2021 | 9 | |
| 12 | 2020 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2021 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2018 | 7 | |
| 17 | 2022 | 7 | |
| 18 | 2023 | 5 | |
| 19 | 2020 | 5 | |
| 20 | 2024 | 5 |
About Luis Cano
Luis Cano is a scholar working on Surgery, Hepatology, Oncology, Epidemiology and Molecular Biology, having authored 34 papers that have together received 330 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Hepatitis B Virus Studies (4 papers), Organ Donation and Transplantation (4 papers), Organ Transplantation Techniques and Outcomes (4 papers), Liver Disease and Transplantation (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Hepatology (93 citations), Oncology (101 citations), Cancer Research (47 citations), Epidemiology (77 citations) and Biophysics (12 citations). Luis Cano has collaborated with scholars based in France, Peru and United States. Frequent co-authors include Miluska Castillo, Sandro Casavilca‐Zambrano, Pascal Pineau, Stéphane Bertani, César Beltrán, Eloy Ruíz, Agnès Marchio, Eric Deharo, António Sá Cunha and Daniel Cherqui. Their work appears in journals such as Scientific Reports, Surgery, Clinical & Translational Oncology, British Journal of Cancer and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.